Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) Yaltormin SR 500mg (metformin hydrochloride) Prolonged Release Tablets
Section 19A approved medicine
(Approval lapsed) Yaltormin SR 500mg (metformin hydrochloride) Prolonged Release Tablets
Section 19A approval holder
Link Medical Products Pty Ltd ABN 730 109 715 16
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
DIABEX XR 500 metformin hydrochloride 500mg extended release tablet blister pack - ARTG 98982
APO-METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 281211
BLOOMS THE CHEMIST METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 278176
CHEMMART METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 197405
DIAFORMIN XR metformin hydrochloride 500mg extended release tablet blister pack - ARTG 120868
METEX XR metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 232661
TERRY WHITE CHEMISTS METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 278180
APO-METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 281211
BLOOMS THE CHEMIST METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 278176
CHEMMART METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 197405
DIAFORMIN XR metformin hydrochloride 500mg extended release tablet blister pack - ARTG 120868
METEX XR metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 232661
TERRY WHITE CHEMISTS METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack - ARTG 278180
Indication(s)
Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. Yaltormin SR may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.